Back
AN2 Therapeutics, Inc. ANTX · Insights
AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, s... Price4
Market Cap176.96 M
Float32.48 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro